Rad AI announced an additional $8 million strategic investment to its latest funding round, led by four of the nation’s most respected health systems: Advocate Health, Memorial Hermann Health System, Corewell Health, and Atlantic Health System.
The additional funding brings Rad AI’s total Series C funding to $68 million. And these partnerships reflect a shared commitment to transform care delivery for millions of patients nationwide and to scale generative AI across hospitals and clinics.
Advocate Health, Memorial Hermann Health System, Corewell Health, and Atlantic Health System are not just investors. They are partners transforming how generative AI is applied across complex clinical environments. Rad AI’s success has always come from understanding and solving real clinical challenges with measurable impact.
As one of the first generative AI companies to achieve widespread adoption in radiology and trusted by thousands of U.S. radiologists, Rad AI builds practical solutions that improve workflow, care quality, and patient outcomes. This investment brings critical insight from leading health systems to accelerate the next wave of AI-driven innovation in healthcare.
This deal extends Rad AI’s $60 million Series C financing round and marks a significant step forward in bringing AI innovation to healthcare providers. And these organizations operate over 100 hospitals and serve millions of patients across the U.S. Their partnership with Rad AI is already enabling system-wide adoption of advanced radiology and follow-up solutions — advancing progress in areas where health systems face the greatest clinical and operational pressure.
Momentum: This funding from some of the most innovative and well-known health systems represents strong alignment with Rad AI’s role as a trusted AI partner. And it builds on Rad AI’s momentum as the category-defining leader in generative AI for healthcare — trusted by many of the nation’s largest health systems and recognized by Deloitte, CB Insights, AuntMinnie, and Accenture.
KEY QUOTES:
“The impact of AI in healthcare is no longer theoretical — it’s happening right now at scale. It’s an honor to collaborate with these leading health systems to expand that impact even further, building solutions that improve care for millions of patients.”
Doktor Gurson, co-founder and CEO of Rad AI
“Advocate Health’s investment in AI solutions reflects our dedication to innovation and our belief that responsibly deployed AI tools can improve the lives of both our health care providers and our patients. By integrating AI solutions directly into our radiologists’ workflows across our enterprise, while maintaining radiologist oversight, we expect to realize improved reporting efficiency, accuracy and quality, all while reducing burnout for our radiologists.”
Andy Crowder, Chief Digital and AI Officer at Advocate Health
“Memorial Hermann invests in AI not just to adapt to technology, but to transform patient care and improve workflows. We are always seeking partners who can deliver measurable impact on outcomes, efficiency and improving the patient experience and Rad AI checks all those boxes.”
Feby Abraham, PhD, executive vice president and chief strategy officer for Memorial Hermann
“We are pleased to invest in a company that is at the forefront of developing technology to make the jobs of physicians more convenient and efficient. The products of Rad AI will help lead to a reduced workload for providers and, most importantly, potential improvements in patient care.”
Christian Rische, vice president and managing director, Corewell Health Ventures
“The Atlantic Venture Studio, part of Atlantic Health System, is committed to investing in and supporting solutions to health care’s biggest challenges. Our investment in AI applications like Rad AI are focused on transforming care by reducing the burden on physicians, improving the quality of care and building healthier communities.”
Doug Hayes, Executive Director, Atlantic Venture Studio
